etwas auf was wir alle warten! dann wärs positiv
Keryx Biopharmaceuticals to Present at 29th Annual J.P. Morgan Healthcare Conference
More News related to KERX Keryx Biopharmaceuticals to Present at 29th Annual J.P. Morgan Healthcare Conference After-Hours Movers 01/03: NDN Higher; BGP, KERX, MPWR, NLY, GMXR, HOMB Lower Keryx Biopharma (KERX) Files $100M Mixed Securities Shelf Keryx Biopharma (KERX) Presents Promising Data for KRX-0401 in Patients with CLL and HL Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Mul More News related to KERX More News related to Press Releases Jefferies Adds Global Head of Technology M&A Investment Banking GOL Announces Guidance for 2011 Integral Systems Awarded $10 Million IDIQ Contract to Modernize Satellite Communications Network for the United States Coast Guard Cutter Fleet CIT, Boeing Announce Order for 38 Next-Generation 737 Airplanes Pet Airways Appoints Andrew Warner as President and Chief Financial Officer More News related to Press Releases Presentation Scheduled for Tuesday, January 11th at 4:00 p.m. PST
January 4, 2011 8:30 AM EST NEW YORK, Jan. 4, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the 29th Annual J.P. Morgan Healthcare Conference, being held January 10-13, 2011 at the Westin St. Francis Hotel in San Francisco. Mr. Bentsur's presentation is scheduled to take place on Tuesday, January 11th, at 4:00 p.m. PST (7:00 p.m. EST).
A live audio webcast of Mr. Bentsur's presentation will be accessible from the Investor Information page of the Company's Website at http://investors.keryx.com. An archived version of the webcast will be available following the conclusion of the live presentation. ----------- "Wenn die klügeren nachgeben, setzen sich die dümmeren durch" |